Isoliquiritigenin Inhibits Ovarian Cancer Metastasis by Reversing Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition (EMT) plays a prominent role in cancer metastasis. Isoliquiritigenin (ISL), one of the flavonoids in licorice, has been shown to exhibit anticancer activities in many cancer types through various mechanisms. However, it is unknown whether ISL impacts the EMT...
Main Authors: | Chen Chen, Shuang Huang, Chang-Liang Chen, Shi-Bing Su, Dong-Dong Fang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-10-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/24/20/3725 |
Similar Items
-
Isoliquiritigenin Reverses Epithelial-Mesenchymal Transition Through Modulation of the TGF-β/Smad Signaling Pathway in Endometrial Cancer
by: Hsin-Yuan Chen, et al.
Published: (2021-03-01) -
Epithelial-mesenchymal transition in ovarian carcinoma
by: Ben eDavidson, et al.
Published: (2012-04-01) -
Epithelial-mesenchymal Transition and Tumor Metastasis
by: Rongzhi ZHAO, et al.
Published: (2011-07-01) -
Epithelial-mesenchymal interconversions in ovarian cancer: the levels and functions of E-cadherin in intraabdominal dissemination
by: Ricardo J. Roque, et al.
Published: (2020-05-01) -
Epithelial-to-Mesenchymal Transition in Metastasis: Focus on Laryngeal Carcinoma
by: Anastasios Goulioumis, et al.
Published: (2022-09-01)